Related Experiment Video
Updated: Feb 16, 2026

07:40
Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
8.3K
Test-Retest Reliability of Two Consecutive Mean Sleep Latency Tests in Patients with Hypersomnia
Younghoon Kwon1,2, Louis Kazaglis2,3,4, Yeilim Cho1
1Department of Medicine, University of Virginia, 1215 Lee Street, Charlottesville, VA 22908, USA.
Sleep and Biological Rhythms
|December 19, 2017
Summary
Mean sleep latency testing (MSLT) is reliable for diagnosing hypersomnia. A single day of testing is sufficient for patients with hypersomnia without cataplexy when using a carefully controlled protocol.
Area of Science:
- Neurology
- Sleep Medicine
- Clinical Neurophysiology
Background:
- The reliability of consecutive daily Mean Sleep Latency Testing (MSLT) in diagnosing hypersomnia, particularly hypersomnia without cataplexy, remains under-investigated.
- Accurate diagnosis of hypersomnolence disorders is crucial for effective patient management and treatment.
Purpose of the Study:
- To evaluate the reliability and consistency of MSLT results over two consecutive days in patients diagnosed with hypersomnia without cataplexy.
- To determine if a single day of MSLT is sufficient for diagnosing pathological hypersomnia under specific protocol conditions.
Main Methods:
- A retrospective review of 29 patients with hypersomnia without cataplexy who completed a two-day consecutive MSLT protocol.
- Analysis of Mean Sleep Latency (MSL) values and agreement for pathological hypersomnia (MSL ≤ 8 minutes) between the two testing days.
- Subgroup analysis was performed for patients without sleep apnea.
Main Results:
- The average MSL was consistent across both days (10.9 minutes on Day 1 and 10.9 minutes on Day 2).
- High agreement was observed for diagnosing pathological hypersomnia between the two MSLT days (k=0.85 overall, k=0.76 in patients without sleep apnea).
Conclusions:
- A single MSLT day is sufficient for diagnosing hypersomnia in patients with subjective complaints when a meticulously controlled protocol is employed.
- The findings suggest that adding a second day of MSLT may not be necessary for patients meeting specific diagnostic criteria and protocol adherence, potentially streamlining the diagnostic process.

